A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
for Atopic Dermatitis
16 locations incl. Lancaster
Sponsor: Inmagene LLC
Sex: All·Age: 18 - 74
Code: NCT07037901·Phase 2·Recruiting